Acumen Pharmaceuticals, Inc.

We’re searching for a Senior Director/Vice President, Program Leader to join our team! At Acumen, we invite our team members to bring their passion, talent, and experience to help shape our culture and enable our mission. Discover more about Acumen and view this opening by clicking below⬇️ https://lnkd.in/gZpRhTkB #Recruitment #HR #Jobopportunity #Hiring #Job

This year, we are supporting the Alzheimer's Association® in their "Walk to End Alzheimer’s" campaign. 👣This past weekend Acumen team members hit the pavement in Charlottesville, VA, Boston, MA and St. Louis, MO. Kudos to Daniel O'Connell, Rebecca Jolin, Yuli Wu, MD and Kristin Aldridge, along with their families and friends for their commitment to the cause! #EndAlz #TeamAcumen #WalkToEndAlzheimers #Walk2ENDALZ

We're excited to be attending this year’s CTAD Clinical Trials on Alzheimer's Disease Conference! If you’re at the conference, don’t miss our late-breaking presentation “ALTITUDE-AD: Use of a Validated p-tau217 Assay to Screen Potential Participants in an Ongoing Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Sabirnetug for Participants with Early Alzheimer's Disease” on Thursday, Oct. 31, at 9:30 a.m. CET. #CTAD24 #Alzheimers 🔗Read the full announcement: https://lnkd.in/gjBaiVUS

This year, we are supporting the Alzheimer's Association® in their "Walk to End Alzheimer’s" campaign. 👣This past weekend Acumen team members hit the pavement in East Ventura County, CA and Dutchess/Ulster County, NY. Kudos to Qahera Munaim & Paul Wynn along with their families and friends for their commitment to the cause! #EndAlz #TeamAcumen #WalkToEndAlzheimers #Walk2ENDALZ

We're proud to be a silver sponsor of UsAgainstAlzheimer's 2024 National Alzheimer's Summit, focused on ushering in a new era of Alzheimer's research and care. This year's event highlights cutting-edge advancements in prevention, detection, and treatment, with a critical focus on ensuring equitable access to innovations for all. #UsA2Summit Learn more here: https://lnkd.in/dz_nDBR

Our team recently attended the Alzheimer Europe 2024 Conference in Geneva, focused on the theme “New Horizons - Innovating for Dementia.” Connecting and collaborating with researchers and advocates from around the world is crucial to advancing innovation and finding better treatments for Alzheimer’s disease.  #34AEC #dementianeedsEU

We’re pleased to share some insights from our Chief Medical Officer, Eric Siemers MD, on the path forward in Alzheimer’s treatment in a recent interview with The Educated Patient. Dr. Siemers highlights that early diagnosis, particularly during mild cognitive impairment (MCI) or early-stage dementia, is key for effective treatment. He also underscores the crucial role of caregivers and how clinical trials play a role in advancing treatments. Watch the full interview: https://lnkd.in/gmgm76bF #Alzheimers #ALZ #Caregiving

#ICYMI: Our R&D Day on October 2nd featured insights into our strategic vision and the development of sabirnetug for Alzheimer’s disease. If you missed it live, don’t worry—you can still catch the webcast! 🧠💡 🔗 https://lnkd.in/gT8v9dH8 #AlzheimersResearch #Innovation

This year, we are supporting the Alzheimer's Association® in their "Walk to End Alzheimer’s" campaign. 👣This past weekend Acumen team members hit the pavement in Bloomington, IN. Kudos to Janice Hitchcock, Ph.D. & Amy Hutchinson along with their families and friends for their commitment to the cause! #EndAlz #TeamAcumen #WalkToEndAlzheimers #Walk2ENDALZ

This year, we are supporting the Alzheimer's Association® in their "Walk to End Alzheimer’s" campaign. 👣This past weekend Acumen team members hit the pavement in Indianapolis, IN. Kudos to Eric Siemers MD & Julie Bockenstette for their commitment to the cause! #EndAlz #TeamAcumen #WalkToEndAlzheimers #Walk2ENDALZ